Topics & People
A primary and highly popular application for GLP-1 drugs, which suppress appetite and reduce 'food noise', leading to significant changes in body weight and BMI.
A dual-agonist GLP-1 and GIP drug marketed by Eli Lilly for metabolic health.
A class of peptide-based drugs, originally developed for diabetes, that have become a cultural and medical phenomenon due to their significant impact on weight loss, appetite suppression, and potential uses in treating addiction and mental health issues.
CEO of Eli Lilly, who provides insights into the development, success, pricing strategy, and future potential of GLP-1 drugs.
A bill (SB771) passed in California that would allow the state to fine social media networks for hosting content that the state deems to be 'hate speech'. The bill is on Governor Gavin Newsom's desk.
The act of suppressing or controlling information and discussions related to the COVID-19 pandemic. YouTube admitted to engaging in this under pressure from the Biden administration.
Running AI model computations (inference) locally on a device (like a phone or robot) rather than in a remote data center. This is enabled by more energy-efficient AI architectures.
The significant amount of electrical power required to train and run AI models. A paper from Germany is discussed which proposes a new architecture that could reduce this energy consumption by tens of thousands of times.
A method in artificial intelligence that involves creating an explicit, step-by-step plan (e.g., state-action-state chains) to solve a problem. An MIT paper is discussed that uses this to improve the reasoning and planning abilities of LLMs.
The concept of politically motivated violence originating from leftist ideologies. The podcast discusses this in the context of the Charlie Kirk assassination and argues that there is a rising trend that needs to be addressed.